Knowledge and perceptions of BRCA1/2 genetic testing and needs of diverse women with a personal or family history of breast cancer in South Florida

被引:2
|
作者
Jones, Tarsha [1 ]
Howard, Heather [2 ]
Freeman-Costin, Katherine [3 ]
Creighton, Ana [1 ]
Wisdom-Chambers, Karen [1 ]
Underhill-Blazey, Meghan [4 ,5 ]
机构
[1] Florida Atlantic Univ, Christine E Lynn Coll Nursing, 777 Glades Rd, Boca Raton, FL 33431 USA
[2] Florida Atlantic Univ, Coll Design & Social Inquiry, Boca Raton, FL 33431 USA
[3] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA
[4] Univ Rochester, Sch Nursing, 601 Elmwood Ave, Rochester, NY 14642 USA
[5] Dana Farber Canc Inst, Boston, MA 02215 USA
关键词
Breast cancer; BRCA1 and BRCA2; Genetic testing; Diverse women; Personal or family history; Qualitative research;
D O I
10.1007/s12687-021-00507-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The vast majority of (BRCA1/2) genetic testing has been conducted in White women, in particular Ashkenazi Jewish women, with limited information available for Black and Hispanic women. Understanding perspectives of those who are underserved is critical to developing interventions to support inclusive approaches to genetic testing. This qualitative study explored knowledge and perceptions of BRCA1/2 genetic testing among diverse women in South Florida. We also explored participants' information needs. Convenience sampling was used to recruit a diverse group of 15 women with a personal or family history of breast cancer. We conducted semi-structured interviews and used grounded theory method to analyze the data. Five themes were identified: (1) lacking awareness and knowledge of BRCA1/2 genetic testing and results among Black women, (2) perceiving BRCA1/2 genetic testing as beneficial to themselves and a way to be proactive about cancer risk, (3) perceiving BRCA1/2 genetic testing as beneficial to family members, (4) interactions with healthcare providers and the healthcare system that shape genetic testing experiences, and (5) information needs for reducing cancer risk and promoting health. Our findings suggest that diverse underserved women perceived genetic testing as beneficial to themselves and family members. Women needed more information about the BRCA genes and genetic testing, prevention strategies, and the latest breast cancer research. Healthcare providers, particularly nurse practitioners, need to engage diverse high-risk women in discussions about their cancer risk, address unmet information needs, and, in particular, educate Black women about the benefits of pursuing genetic testing.
引用
收藏
页码:415 / 429
页数:15
相关论文
共 50 条
  • [21] Genetic testing for breast cancer susceptibility:: Frequency of BRCA1 and BRCA2 mutations
    Ganguly, A
    Leahy, K
    Marshall, AM
    Dhulipala, R
    Godmilow, L
    Ganguly, T
    [J]. GENETIC TESTING, 1997, 1 (02): : 85 - 90
  • [22] Family history of cancer in Italian women attending a breast unit: evaluation of criteria for referral to a genetics clinic and for BRCA1 and BRCA2 testing
    Angiolini, C
    Rossi, C
    Bonelli, L
    Varesco, L
    Gismondi, V
    Massa, T
    Parodi, GC
    Crotti, N
    Bruzzi, P
    Santi, L
    [J]. BREAST, 1997, 6 (05): : P914 - P914
  • [23] Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing
    Hamann, HA
    Somers, TJ
    Smith, AW
    Inslicht, SS
    Baum, A
    [J]. PSYCHOSOMATIC MEDICINE, 2005, 67 (05) : 766 - 772
  • [24] Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses
    Bluman, LG
    Rimer, BK
    Sterba, KR
    Lancaster, J
    Clark, S
    Borstelmann, N
    Iglehart, JD
    Winer, EP
    [J]. PSYCHO-ONCOLOGY, 2003, 12 (05) : 410 - 427
  • [25] Clinical Impact of Multigene Panel Testing in Patients with a Personal or Family History of Breast or Ovarian Cancer Previously Negative for BRCA1/2 Genes
    Miller, Devon
    Pritzl, Stephanie
    Tess, Angela
    Gooding, Jessica
    Barroilhet, Lisa
    Dubenske, Lori
    Wisinski, Kari
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [26] The prospective risk of ovarian cancer in 1433 women in a breast cancer family history clinic: no increased risk in families testing negative for BRCA1 and BRCA2
    Evans, D. G. R.
    Ingham, S. L.
    Sahin, S.
    Buchan, I.
    Warwick, J.
    O'Hara, C.
    Moran, A.
    Howell, A.
    [J]. CANCER RESEARCH, 2012, 72
  • [27] Family history of breast/ovarian cancer and referral criteria for a BRCA1 testing program.
    Bajdik, CD
    Raboud, JM
    Schechter, MT
    Gallagher, RP
    McGillivray, BC
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S55 - S55
  • [28] Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation
    Metcalfe, K. A.
    Finch, A.
    Poll, A.
    Horsman, D.
    Kim-Sing, C.
    Scott, J.
    Royer, R.
    Sun, P.
    Narod, S. A.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 100 (02) : 421 - 425
  • [29] Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation
    K A Metcalfe
    A Finch
    A Poll
    D Horsman
    C Kim-Sing
    J Scott
    R Royer
    P Sun
    S A Narod
    [J]. British Journal of Cancer, 2009, 100 : 421 - 425
  • [30] PERCEPTIONS AND EXPERIENCES OF WOMEN TESTING POSITIVE FOR BRCA1/2 GENETIC MUTATIONS: A QUALITATIVE ANALYSIS
    Dibble, Kate E.
    Donorfio, Laura K.
    Britner, Preston A.
    Kessler, Trane
    Atehortua, Valentina
    Anderson, Annika R.
    Chan, Jason
    Bellizzi, Keith M.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2020, 54 : S273 - S273